Prescription drugs have often been subjected to abuse as a result of inadequate control measures. Therefore, evaluation of Prescription Drug Monitoring Program is essential with the aim of ensuring that drugs are not abused. Various Prescription Drug Monitoring Programs have been implemented in various states across the country. However, each state has its own unique system and approach towards monitoring prescription drugs. A Prescription Drug Monitoring Program determines the nature, extent and prescription drugs that require monitoring. In addition, it describes where, how and when prescription drugs are most likely to be abused and the respective measures that must be taken to prevent it from occurring. In addition, data on various prescription drug dynamics are controlled to ensure that they are not accessed by wrong people.
Read also: "Academic Book Review: How to Complete It"
The statistics for the deaths of overdosing drugs and drug abuse were much worse in the past; consequently, leading to the development of the Prescription Drug Monitoring Program in the United States by the government. When the program was initiated, it started tracking drugs that were distributed and approving drugs before they hit the market (Gugelmann, Perrone, & Nelson, 2012). Furthermore, the program stipulated punitive measures to be taken against those who prescribed wrong medicines or did not follow pre-defined procedure when prescribing drugs, hence leading to increased cases of overdose.
The impact of the Perception Drug Monitoring Program is that the organization can track prescription drugs that pharmacies give away to patients by bar codes on the prescription drugs so they can keep track how pharmacies distribute prescription drugs. Also, one of the impacts of the Prescription Drug Monitoring Program is that it helped a lot with duration it took to get an investigation done for the case. Research also suggests that the Prescription Drug Monitoring Program had an impact on both law enforcement and health care (Finklea, Bagalman & Sacco, 2013).
According to the Congressional Research Service, the Prescription Drug Monitoring Program, especially the one that issues reports proactively, changes prescriber behavior in a way that per capita supplies prescription of pain relievers and stimulants reduces; which in turn reduces the likelihood of abuse (Finklea, Bagalman, & Sacco, 2013). Research also showed that drug abuse increase is slower in states with Prescription Drug Monitoring Program than in the states that do not have the Prescription Drug Monitoring Program.
The primary stakeholders in this program include the American Medical Association, the federal government, the Generic Pharmaceutical Association, law enforcement, health care providers and community-based organizations (Finklea, Bagalman, & Sacco, 2013). The local governments fund the Prescription Drug Monitoring Program; the fund goes into the hardware such as servers and software to run the Prescription Drug Monitoring Program database and insure that the information is secure.
The use of technology in the Prescription Drug Monitoring Program can keep track of prescription drugs both within the country and abroad to prevent illegal distribution (Gugelmann, Perrone, & Nelson, 2012). Pharmaceutical companies are distributors and responsible for the rules and law by what is distributed and make sure that prescription drugs are locked and safe from stealing. These stakeholders should come together to raise awareness about misuse of prescription drug.
In addition, there should be punitive actions for those who fail to adhere to the regulation for prescribing drugs and distributing them. Recently such drugs as marijuana have been legalized in some states; it is not something that can only be found in the streets. Essentially, a physician can prescribe the drug to anyone; therefore, the Prescription Drug Monitoring Program should be at top notch and do its best, because people go to doctor shopping for drugs (Finklea, Bagalman & Sacco, 2013).
Among the intervention strategies are the proposals in congress that aimed at making the state-level databases much better, sharing of interstate information and making a national system. Nevertheless, as time went by, the congresses focused more on the system at the state level and improve how information is exchanged statewide. It aimed at enabling the Prescription Drug Monitoring Program to track drug abuse in a more quick and efficient manner (Gugelmann, Perrone, & Nelson, 2012). Meanwhile, states have started to receive federal grants to support their Prescription Drug Monitoring Programs. The results of enhancing the program are that the time it takes to track down prescription drug abuse has dropped significantly and made it easier for legal authority to track it down. Recommendations would be to try to improve the system for the Prescription Drug Monitoring Program to a state, where the rate of drug abused is much lower than in the past (Finklea, Bagalman, & Sacco, 2013). However, it is not enough. The improvement should make it to a level where decreasing prescription drug abuse should be decreased and slowly eliminated, consequently, eliminating the problem.
The system used for this program is an in-state system. The system, as far as security issues are concerned, is adequately secure. People from the Prescription Drug Monitoring Program are the only people who can access the database and only those who have the authority from the law enforcement. The privacy issue that the Prescription Drug Monitoring Program is with the patients right for privacy for their information, so there is an issue with accessing Patients information to monitor their drug use and HIPPAs law for the privacy of patient information (Finklea, Bagalman, & Sacco, 2013). Therefore, the Prescription Drug Monitoring Program requires organizations, such as pharmaceutical companies, to give information about drug dispensed and patient information. However, HIPPA requires these organizations to follow regulations for patients privacy, so the Prescription Drug Monitoring Program and HIPPA requirements conflict with each other (Finklea, Bagalman & Sacco, 2013).
There is a significant number of sectors that get funds for their programs and have high priority. However, the Prescription Drug Monitoring Program is among the top programs that should be allocated significant funding. The impact of unregulated prescription drug industry could be detrimental. For instance, teenagers and children are affected by drug abuse. Many irresponsible physicians are giving overdose of drugs to patients, who either get affected by those drugs or even die. It leads to the conclusion that the Prescription Drug Monitoring Program is very important program to keep track of prescription drugs, prevent drug abuse and save lives.